16 research outputs found

    Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

    Get PDF
    Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the United Kingdom to accelerate population coverage with a single dose. At this time, trial data were lacking, and we addressed this in a study of United Kingdom healthcare workers. The first vaccine dose induced protection from infection from the circulating alpha (B.1.1.7) variant over several weeks. In a substudy of 589 individuals, we show that this single dose induces severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) neutralizing antibody (NAb) responses and a sustained B and T cell response to the spike protein. NAb levels were higher after the extended dosing interval (6–14 weeks) compared with the conventional 3- to 4-week regimen, accompanied by enrichment of CD4+ T cells expressing interleukin-2 (IL-2). Prior SARS-CoV-2 infection amplified and accelerated the response. These data on dynamic cellular and humoral responses indicate that extension of the dosing interval is an effective immunogenic protocol

    Changes in bite force after orthognathic surgical correction of mandibular prognathism: a systematic review

    No full text
    10.1016/j.ijom.2017.01.012INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY466746-75

    Unusual metastatic presentations of a primary right parapharyngeal acinic cell adenocarcinoma

    No full text
    10.1016/j.ijom.2019.09.012INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY495564-56

    The role of anterior segmental osteotomies in orthognathic surgery for protrusive faces in a Southeast Asian population: 10-year retrospective data of 51 patients treated in a single centre

    No full text
    10.1016/j.ijom.2022.08.013International Journal of Oral and Maxillofacial Surgery524468-47

    Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer’s disease.

    Get PDF
    Changes to lipid metabolism are tightly associated with the onset and pathology of Alzheimer’s disease (AD). Lipids are complex molecules comprising many isomeric and isobaric species, necessitating detailed analysis to enable interpretation of biological significance. Our expanded targeted lipidomics platform (569 species across 32 classes) allows for detailed lipid separation and characterisation. In this study we examined peripheral samples of two cohorts (AIBL, n = 1112 and ADNI, n = 800). We are able to identify concordant peripheral signatures associated with prevalent AD arising from lipid pathways including; ether lipids, sphingolipids (notably GM3 gangliosides) and lipid classes previously associated with cardiometabolic disease (phosphatidylethanolamine and triglycerides). We subsequently identified similar lipid signatures in both cohorts with future disease. Lastly, we developed multivariate lipid models that improved classification and prediction. Our results provide a holistic view between the lipidome and AD using a comprehensive approach, providing targets for further mechanistic investigation
    corecore